Cholesterol Treatment: A Review of the Clinical Trials Evidence
PEMD-96-7
Published: May 14, 1996. Publicly Released: Jun 13, 1996.
Skip to Highlights
Highlights
Pursuant to a congressional request, GAO reviewed the evidence from clinical trials that the National Heart, Lung, and Blood Institute (NHLBI) used to develop its National Cholesterol Education Program guidelines.
Recommendations
Recommendations for Executive Action
| Agency Affected | Recommendation | Status |
|---|---|---|
| National Heart, Lung, and Blood Institute | The Director, NHLBI, should take steps to closely monitor trials now under way, evaluate their outcomes, and determine whether additional trials should be planned in order to fill in data presently lacking on women, elderly men and women, minority men and women, and persons whose cholesterol levels are relatively low or who otherwise are members of low-risk groups. |
NIH concurred with GAO's recommendation and continues to monitor and evaluate the results of ongoing clinical trials.
|
Full Report
Public Inquiries
Topics
Cardiovascular diseasesDrugsHealth hazardsHealth statisticsMedical researchNutrition researchPharmacological researchPublic health researchWomenCholesterol